Xiao-Jian Zhou

5PUBLICATIONS
4CO-AUTHORS
PharmacogenomicsMedical virologyMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 04, 2026
Multiscale Modeling of an 8-Week Combination Regimen of Bemnifosbuvir and Ruzasvir in Patients with Chronic Hepatitis C Virus Infection.

|May 25, 2026
Bemnifosbuvir: An HCV NS5B Inhibitor With Multiple Modes of Action.

|Apr 29, 2026
In Vitro and Clinical Evaluation of Potential Interactions of Bemnifosbuvir with Drug-Metabolizing Enzymes.

|Mar 25, 2024
First-in-human trial evaluating safety and pharmacokinetics of AT-752, a novel nucleotide prodrug with pan-serotype activity against dengue virus.

Xiao-Jian Zhou, Jason Lickliter, Maureen Montrond

|Jan 24, 2024
Bemnifosbuvir (BEM, AT-527), a novel nucleotide analogue inhibitor of the hepatitis C virus NS5B polymerase.

Xiao-Jian Zhou, Steven S Good, Keith Pietropaolo

Pageof 1

Frequent Collaborators

2 joint publications

Carolin Zitzmann

2 joint publications

Ruy M Ribeiro

2 joint publications

Aurélien Marc

2 joint publications

Alan S Perelson